LDX Equity Value before Product Revenue is around 18.6c or $82.6m market cap.
This is before multiple stream future product revenue and a potential $2.5 billion USD annual healthcare cost saving in America alone if FebriDx was implemented for ARI (Acute Respiratory Infection) cases.
Giddy Up LDX!!
2277186_Economic-Evaluation-of-FebriDx.pdf (lumosdiagnostics.com)
Economic Evaluation of FebriDx®: A Novel Rapid, Point-of-Care Test for Differentiation of Viral versus Bacterial Acute Respiratory Infection in the United States | Published in Journal of Health Economics and Outcomes Research (jheor.org)
- Forums
- ASX - By Stock
- LDX
- LDX Chart
LDX
lumos diagnostics holdings limited
Add to My Watchlist
0.00%
!
2.7¢

LDX Chart, page-127
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.21M |
Open | High | Low | Value | Volume |
2.7¢ | 2.7¢ | 2.6¢ | $24.71K | 917.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 274085 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 989898 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 274085 | 0.026 |
10 | 1316132 | 0.025 |
1 | 1238229 | 0.024 |
1 | 40000 | 0.023 |
2 | 48000 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 989898 | 5 |
0.029 | 18289 | 1 |
0.030 | 221800 | 1 |
0.031 | 309 | 1 |
0.032 | 71725 | 2 |
Last trade - 15.56pm 25/06/2025 (20 minute delay) ? |
Featured News
LDX (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online